Close Menu

The firm noted that its study showed strong performance data, including high sensitivity and high specificity, in providing results direct from blood.

The QiaStat-Dx system will now be commercially available in the US along with a panel that detects more than 20 respiratory viral and bacterial pathogens.

Oxford Immunotec said that it expects the report to further the trend toward interferon-gamma release assay adoption for healthcare personnel screening.